ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,604.37
(
0.41%
)
US Tech 100
15,700.80
(
0.54%
)
Dow Jones
36,247.87
(
0.36%
)
Brent Oil
75.965
(
0.0%
)
Bitcoin
44,129.68
(
-0.12%
)
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Gain Therapeutics Inc (GANX)

  7. Gain Therapeutics Inc (GANX) News

GANX Gain Therapeutics Inc

2.72
0.20 (7.94%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Gain Therapeutics Inc GANX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.20 7.94% 2.72 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.54 2.54 2.95 2.72 2.52
more quote information »

Recent News

Date Time Source Heading
12/01/202308:00GLOBEGain Therapeutics Announces Preclinical Data Showing..
11/29/202308:00GLOBEGain Therapeutics to Participate in AI Driven Drug Discovery..
11/24/202313:01GLOBEGain Therapeutics Announces Closing of $10.1 Million Public..
11/24/202306:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/22/202317:27EDGAR2Form 8-K - Current report
11/21/202308:54GLOBEGain Therapeutics Announces Pricing of $9.4 Million Public..
11/20/202316:22EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/20/202316:03GLOBEGain Therapeutics Announces Proposed Public Offering
11/17/202316:27EDGAR2Form 8-K - Current report
11/14/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/202316:02EDGAR2Form 8-K - Current report
11/14/202307:00GLOBEGain Therapeutics Announces Third Quarter 2023 Financial..
10/04/202307:00GLOBEGain Therapeutics Announces Dosing of First Two Subjects in..
9/25/202316:05GLOBEGain Therapeutics to Participate at Cantor Fitzgerald Global..
9/20/202316:05GLOBEGain Therapeutics to Present at the Cambridge Healthtech..
9/12/202309:25GLOBEGain Therapeutics Receives Approval to Commence Phase 1..
8/10/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:02EDGAR2Form 8-K - Current report
8/10/202307:00GLOBEGain Therapeutics Announces Second Quarter 2023 Financial..
8/07/202307:00GLOBEGain Therapeutics Announces Acceptance of Late Breaking..
7/31/202308:00GLOBEGain Therapeutics to Participate in the 2023 BTIG Virtual..
6/01/202308:00GLOBEGain Therapeutics to Present at the Jefferies Healthcare..
5/12/202308:00GLOBEGain Therapeutics Reports First Quarter 2023 Financial..
5/03/202309:15GLOBEGain Therapeutics Awarded CHF 2.5 million Innosuisse Grant..
4/12/202316:30GLOBEGain Therapeutics Appoints C. Evan Ballantyne as Chief..
3/29/202308:52GLOBEGain Therapeutics to Present Positive Preclinical Data on..
3/23/202316:05GLOBEGain Therapeutics Reports Full Year 2022 Financial Results..
3/22/202308:30GLOBEGain Therapeutics to Participate in Virtual Fireside Chat On..
3/21/202308:00GLOBEGain Therapeutics Announces Grant Award by Eurostars with..
3/09/202308:00GLOBEGain Therapeutics to Participate in the Oppenheimer 33rd..
2/27/202308:00GLOBEGain Therapeutics Presents New Preclinical Data from its..
2/02/202308:00GLOBEGain Therapeutics to Participate in Upcoming Scientific and..
1/12/202316:05GLOBEGain Therapeutics to Present at Sidoti Small-Cap..

Your Recent History

NASDAQ
GANX
Gain Therapeutics
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com